BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18202962)

  • 1. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
    Lucas R; Barros H
    Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported data on reproductive variables were reliable among postmenopausal women.
    Lucas R; Azevedo A; Barros H
    J Clin Epidemiol; 2008 Sep; 61(9):945-50. PubMed ID: 18468857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hormone replacement therapy (HRT) among women aged 45-64 years in the German EPIC-cohorts.
    Nagel G; Lahmann PH; Schulz M; Boeing H; Linseisen J
    Maturitas; 2007 Apr; 56(4):436-46. PubMed ID: 17194554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
    Thunell L; Stadberg E; Milsom I; Mattsson LA
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.
    Schneider HP
    Int J Fertil Womens Med; 1997; 42 Suppl 2():365-75. PubMed ID: 9397384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral symptoms at menopause--the role of hormone replacement therapy.
    Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The menopause symptom profile of Maori and non-Maori women in New Zealand.
    Lawton BA; Rose SB; Cormack DM; Stanley J; Dowell AC
    Climacteric; 2008; 11(6):467-74. PubMed ID: 18802815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle factors and choice of hormone replacement therapy among Danish nurses.
    Hundrup YA; Thoning H; Obel EB; Rasmussen NK; Philip J
    Scand J Public Health; 2002; 30(1):47-53. PubMed ID: 11928833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.